![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/SMSPHARMA.png)
Share the post "SMS PHARMACEUTICALS ‘s Q3 2024-25 Latest News: Profit Rises by 58.89% YoY"
Highlights
🔹 The presented financial data is Consolidated to provide a comprehensive overview of the company performance. 🔹 Sales over the Year and quarter: The company experienced a substantial growth of 7.35 % in the past year, decrease in net sales/revenue by -11.89 %. 🔹 Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 42.72 %. Marginal increase in other income during this quarter, up by 63.07%. 🔹 Profit over the Year and quarter: Significant improvement in profitability for SMS PHARMACEUTICALS LTD.. Notable increase of 58.9 % in net profit Year to Year, SMS PHARMACEUTICALS LTD.’s profitability increased by 29.39 % in this quarter. 🔹 EPS over the Year and quarter: EPS increased by 58.09 % Year to Year. EPS increased by 27.22 % in previous quarter. Positive impact on shareholders.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 161.482 Cr | Rs. 196.748 Cr | Rs. 173.353 Cr | -11.89 % | + 7.35 % |
| Expenses | Rs. 133.3 Cr | Rs. 165.28 Cr | Rs. 140.15 Cr | -15.2 % | + 5.14 % |
| Operating Profit | Rs. 28.18 Cr | Rs. 31.47 Cr | Rs. 33.2 Cr | + 5.5 % | + 17.81 % |
| OPM % | 17.45 % | 16 % | 19.15 % | + 3.15 % | + 1.7 % |
| Other Income | Rs. 1.491 Cr | Rs. 1.305 Cr | Rs. 2.128 Cr | + 63.07 % | + 42.72 % |
| Interest | Rs. 5.95 Cr | Rs. 4.61 Cr | Rs. 4.2 Cr | -8.89 % | -29.41 % |
| Depreciation | Rs. 8.01 Cr | Rs. 8.62 Cr | Rs. 8.7 Cr | + 0.93 % | + 8.61 % |
| Profit before tax | Rs. 15.71 Cr | Rs. 19.55 Cr | Rs. 22.43 Cr | + 14.73 % | + 42.78 % |
| Tax % | 25.62 % | 29.07 % | 23.89 % | -5.18 % | -1.73 % |
| Net Profit | Rs. 11.48 Cr | Rs. 14.1 Cr | Rs. 18.24 Cr | + 29.36 % | + 58.89 % |
| EPS in Rs | Rs. 1.36 | Rs. 1.69 | Rs. 2.15 | + 27.22 % | + 58.09 % |
Today, we’re looking at SMS PHARMACEUTICALS LTD.’s financial performance for the Q3(Dec 2024-25).Starting with the top line, the company reported a robust year-over-year sales growth of 7.35 %. However, it did see a marginal slip of -11.89 % from the previous quarter. Expenses decreased slightly by -15.2 % quarter-on-quarter, aligning with the annual rise of 5.14 %. Operating profit, while up 17.81 % compared to last year, faced a quarter-on-quarter increase of 5.5 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 1.7 %, but an expansion of 3.15 % sequentially. Other income rose by 63.07 % compared to the last quarter, despite an annual growth of 42.72 %. Interest expenses dropped significantly by -8.89 % from the previous quarter, yet the year-over-year decrease remains at a moderate -29.41 %. Depreciation costs climbed by 0.93 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 8.61 %. Profit before tax grew annually by 42.78 % but saw an increase from the preceding quarter by 14.73 %.
Tax expenses as a percentage of profits decreased slightly by -1.73 % compared to last year, with a more notable quarter-on-quarter decrease of -5.18 %. Net profit rose by 58.89 % year-on-year but experienced a 29.36 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 58.09 % but a quarterly rise of 27.22 %. In summary, SMS PHARMACEUTICALS LTD.’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 161.482 Cr | Rs. 196.748 Cr | Rs. 173.353 Cr | -11.89 % | + 7.35 % |
| Expenses | Rs. 133.3 Cr | Rs. 165.28 Cr | Rs. 140.15 Cr | -15.2 % | + 5.14 % |
| Operating Profit | Rs. 28.18 Cr | Rs. 31.47 Cr | Rs. 33.2 Cr | + 5.5 % | + 17.81 % |
| Net Profit | Rs. 11.48 Cr | Rs. 14.1 Cr | Rs. 18.24 Cr | + 29.36 % | + 58.89 % |
| EPS in Rs | Rs. 1.36 | Rs. 1.69 | Rs. 2.15 | + 27.22 % | + 58.09 % |
In reviewing SMS PHARMACEUTICALS LTD.’s 2024-25(Q3) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 7.35 % year-on-year growth, although there was a slight dip of -11.89 % from the previous quarter. Expenses rose by 5.14 % compared to the previous year, with a decrease of -15.2 % quarter-on-quarter. Operating Profit surged by 17.81 % annually, and saw a 5.5 % increase from the last quarter.
Net Profit showed yearly increase of 58.89 %, and experienced a 29.36 % increase from the previous quarter. Earnings Per Share (EPS) rose by 58.09 % annually, however rose by 27.22 % compared to the last quarter. In essence, while SMS PHARMACEUTICALS LTD. exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/ADVAIT.png)
![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/HIGHENE.png)